Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Amerilab Technologies

Amerilab Technologies
1995 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Manufacturer of effervescent and non-effervescent dietary supplements. The company engages in contract development, analytical testing and packaging of effervescent tablets and powders.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • 2765 Niagara Lane North
  • Plymouth, MN 55447
  • United States

+1 (866) 000-0000

Amerilab Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Amerilab Technologies‘s full profile, request access.

Request full access to PitchBook

Amerilab Technologies Executive Team (1)

Name Title Board
Seat
Contact
Info
Fred Wehling Founder & Chief Executive Officer